Postpartum hemorrhage (PPH) (Maternal Hemorrhage) is the leading cause of maternal mortality. All women who carry a pregnancy beyond 20 weeks’ gestation are at risk for PPH and its sequelae.
The Joint Commissions new Standard to address complications in maternal hemorrhage and severe hypertension/preeclampsia will be effective July 1, 2020. This includes a proactive prevention program around strategies for the management of maternal hemorrhage that are outlined in new Provision of Care, Treatment, and Services standard PC.06.01.01: Reduce the likelihood of harm related to maternal hemorrhage.
Maternal hemorrhage is defined by the American College of Obstetricians and Gynecologists (ACOG) as a cumulative blood loss of greater than or equal to 1,000 mL, or blood loss accompanied by signs or symptoms of hypovolemia, within 24 hours after the birth process. Approximately three to five percent of obstetric patients will experience a postpartum hemorrhage. These preventable events are the cause of 27% of maternal deaths worldwide, and 11.2% of U.S. maternal deaths.
Strategies to reduce morbidity and mortality from postpartum hemorrhage have included the use of standardized, comprehensive, obstetric safety bundles that address every patient, patient risk factors, recognition of post-partum bleeding and supplies/medications on hand to immediately address any hemorrhage that presents. A comprehensive plan now, will not only help prevent deaths associated to hemorrhage but will have your organization prepared for compliance.